Narrow search
Showing 1 - 10 of 378
Cover Image
Excessive financialization and "Original Sin Theory" : redemption from corporate reputation
Wang, Hanying; Qi, Ju; Li, Zhuohua; Sensoy, Ahmet; … - In: Research in international business and finance 70 (2024) 1, pp. 1-15
Persistent link: https://www.econbiz.de/10015053377
Cover Image
New evidence on determinants of price momentum in the Japanese stock market
Teplova, Tamara V.; Mikova, Evgeniya - In: Research in international business and finance 34 (2015), pp. 84-109
Persistent link: https://www.econbiz.de/10011325752
Cover Image
Global terrorism and adaptive expectations in financial markets: Evidence from Japanese equity market
Graham, Michael A.; Ramiah, Vikash B. - In: Research in international business and finance 26 (2012) 1, pp. 97-119
Persistent link: https://www.econbiz.de/10009384352
Cover Image
Ripple effects of the 2011 Japan earthquake on international stock markets
Valizadeh, Pourya; Karali, Berna; Ferreira, Susana - In: Research in international business and finance 41 (2017), pp. 556-576
Persistent link: https://www.econbiz.de/10011914587
Cover Image
Is soft information substitutive or complementary to hard news for investor attention? : evidence from corporate advertising in Japan
Aman, Hiroyuki; Kasuga, Norihiro; Moriyasu, Hiroshi - In: Research in international business and finance 66 (2023), pp. 1-14
Persistent link: https://www.econbiz.de/10014463121
Cover Image
ESG reputational risk and market valuation : evidence from the European banking industry
Mandas, Marco; Lahmar, Oumaima; Piras, Luca; De Lisa, … - In: Research in international business and finance 69 (2024), pp. 1-
Persistent link: https://www.econbiz.de/10015052888
Cover Image
Corporate misconduct and innovation : evidence from the pharmaceutical industry
Unsal, Omer; Hippler, William J. - In: Research in international business and finance 71 (2024), pp. 1-17
We examine the relationship between corporate misconduct and pharmaceutical firm innovation and performance. Pharmaceutical firms obtain significantly fewer new product approvals by the U.S. Food and Drug Administration (FDA) following corporate regulatory violations, lawsuits, and Securities...
Persistent link: https://www.econbiz.de/10015062459
Cover Image
Financial crisis, GDP variation and earnings management in Europe
Dimitras, Augustinos I.; Kyriakou, Maria I.; Iatridis, … - In: Research in international business and finance 34 (2015), pp. 338-354
Persistent link: https://www.econbiz.de/10011326208
Cover Image
Cross-national differences in access to finance : influence of culture and institutional environments
Aggarwal, Raj; Goodell, John W. - In: Research in international business and finance 31 (2014), pp. 193-211
Persistent link: https://www.econbiz.de/10010434000
Cover Image
Internationalization, product development and performance outcomes : a comparative study of 10 countries
Hong, Paul; Roh, James Jungbae - In: Research in international business and finance 23 (2009) 2, pp. 169-180
Persistent link: https://www.econbiz.de/10003844474